OKUR Earnings OnKure Therapeutics, Inc.
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–20 of 20
| Q1 2026 | 2026-03-31 | -1.11 | 2026-05-05 | 10-Q |
| FY 2025 | 2025-12-31 | -4.40 | 2026-03-12 | 10-K |
| Q3 2025 | 2025-09-30 | -3.41 | 2025-11-06 | 10-Q |
| Q2 2025 | 2025-06-30 | -2.33 | 2025-08-12 | 10-Q |
| Q1 2026 | 2025-03-31 | -1.19 | 2026-05-05 | 10-Q |
| FY 2025 | 2024-12-31 | -15.28 | 2026-03-12 | 10-K |
| Q3 2025 | 2024-09-30 | -111.77 | 2025-11-06 | 10-Q |
| Q2 2025 | 2024-06-30 | -75.22 | 2025-08-12 | 10-Q |
| Q1 2025 | 2024-03-31 | -30.37 | 2025-05-06 | 10-Q |
| FY 2024 | 2023-12-31 | -124.41 | 2025-03-10 | 10-K |
| Q3 2024 | 2023-09-30 | -18.11 | 2024-11-07 | 10-Q |
| Q2 2024 | 2023-06-30 | -1.25 | 2024-08-13 | 10-Q |
| Q1 2024 | 2023-03-31 | -0.60 | 2024-05-07 | 10-Q |
| FY 2023 | 2022-12-31 | -2.12 | 2024-03-28 | 10-K |
| Q3 2023 | 2022-09-30 | -1.57 | 2023-11-13 | 10-Q |
| Q2 2023 | 2022-06-30 | -1.04 | 2023-08-10 | 10-Q |
| Q1 2023 | 2022-03-31 | -0.53 | 2023-05-11 | 10-Q |
| FY 2022 | 2021-12-31 | -2.19 | 2023-03-27 | 10-K |
| Q3 2022 | 2021-09-30 | -1.82 | 2022-11-08 | 10-Q |
| Q2 2022 | 2021-06-30 | -1.40 | 2022-08-09 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.